Horinaka M - Search Results

1

Efficacy of Low-Dose Aspirin in Colorectal Cancer Risk Prevention is Dependent on ADH1B and ALDH2 Genotype in Japanese Familial Adenomatous Polyposis Patients.

Mure K, Ishikawa H, Mutoh M, Horinaka M, Otani T, Suzuki S, Wakabayashi K, Sakai T; J-FAPP Study IV group. Mure K, et al. Among authors: horinaka m. Cancer Res Commun. 2022 Jun 23;2(6):483-488. doi: 10.1158/2767-9764.CRC-22-0088. eCollection 2022 Jun. Cancer Res Commun. 2022. PMID: 36923554 Free PMC article.

2

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.

Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T. Nakata S, et al. Among authors: horinaka m. Oncogene. 2004 Aug 19;23(37):6261-71. doi: 10.1038/sj.onc.1207830. Oncogene. 2004. PMID: 15208660

3

Differential response at the hGABP/E4TF1 site of retinoblastoma gene promoter in human testicular seminoma cells.

Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Shiraishi T, et al. Among authors: horinaka m. Oncol Rep. 2005 May;13(5):871-4. Oncol Rep. 2005. PMID: 15809752

4

The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells.

Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, Nishino H, Sakai T. Horinaka M, et al. Biochem Biophys Res Commun. 2005 Aug 5;333(3):833-8. doi: 10.1016/j.bbrc.2005.05.179. Biochem Biophys Res Commun. 2005. PMID: 15963948

5

Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein.

Yoshida T, Shiraishi T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Yoshida T, et al. Among authors: horinaka m. Cancer Res. 2005 Jul 1;65(13):5662-7. doi: 10.1158/0008-5472.CAN-05-0693. Cancer Res. 2005. PMID: 15994939

6

Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells.

Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, Nishino H, Matsui H, Sakai T. Horinaka M, et al. Oncogene. 2005 Nov 3;24(48):7180-9. doi: 10.1038/sj.onc.1208874. Oncogene. 2005. PMID: 16007131

7

Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.

Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Shiraishi T, et al. Among authors: horinaka m. Cancer Res. 2005 Jul 15;65(14):6364-70. doi: 10.1158/0008-5472.CAN-05-0312. Cancer Res. 2005. PMID: 16024639

8

Quercetin induces gadd45 expression through a p53-independent pathway.

Yoshida T, Maeda A, Horinaka M, Shiraishi T, Nakata S, Wakada M, Yogosawa S, Sakai T. Yoshida T, et al. Among authors: horinaka m. Oncol Rep. 2005 Nov;14(5):1299-303. Oncol Rep. 2005. PMID: 16211300

9

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand.

Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Sakai T. Horinaka M, et al. Mol Cancer Ther. 2006 Apr;5(4):945-51. doi: 10.1158/1535-7163.MCT-05-0431. Mol Cancer Ther. 2006. PMID: 16648565

10

15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.

Nakata S, Yoshida T, Shiraishi T, Horinaka M, Kouhara J, Wakada M, Sakai T. Nakata S, et al. Among authors: horinaka m. Mol Cancer Ther. 2006 Jul;5(7):1827-35. doi: 10.1158/1535-7163.MCT-06-0023. Mol Cancer Ther. 2006. PMID: 16891469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page